Cargando…
A Novel HMM-Based Method for Detecting Enriched Transcription Factor Binding Sites Reveals RUNX3 as a Potential Target in Pancreatic Cancer Biology
BACKGROUND: Pancreatic adenocarcinoma (PAC) is one of the most intractable malignancies. In order to search for potential new therapeutic targets, we relied on computational methods aimed at identifying transcription factor binding sites (TFBSs) over-represented in the promoter regions of genes diff...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3008686/ https://www.ncbi.nlm.nih.gov/pubmed/21203558 http://dx.doi.org/10.1371/journal.pone.0014423 |
_version_ | 1782194534626623488 |
---|---|
author | Levkovitz, Liron Yosef, Nir Gershengorn, Marvin C. Ruppin, Eytan Sharan, Roded Oron, Yoram |
author_facet | Levkovitz, Liron Yosef, Nir Gershengorn, Marvin C. Ruppin, Eytan Sharan, Roded Oron, Yoram |
author_sort | Levkovitz, Liron |
collection | PubMed |
description | BACKGROUND: Pancreatic adenocarcinoma (PAC) is one of the most intractable malignancies. In order to search for potential new therapeutic targets, we relied on computational methods aimed at identifying transcription factor binding sites (TFBSs) over-represented in the promoter regions of genes differentially expressed in PAC. Though many computational methods have been implemented to accomplish this, none has gained overall acceptance or produced proven novel targets in PAC. To this end we have developed DEMON, a novel method for motif detection. METHODOLOGY: DEMON relies on a hidden Markov model to score the appearance of sequence motifs, taking into account all potential sites in a promoter of potentially varying binding affinities. We demonstrate DEMON's accuracy on simulated and real data sets. Applying DEMON to PAC-related data sets identifies the RUNX family as highly enriched in PAC-related genes. Using a novel experimental paradigm to distinguish between normal and PAC cells, we find that RUNX3 mRNA (but not RUNX1 or RUNX2 mRNAs) exhibits time-dependent increases in normal but not in PAC cells. These increases are accompanied by changes in mRNA levels of putative RUNX gene targets. CONCLUSIONS: The integrated application of DEMON and a novel differentiation system led to the identification of a single family member, RUNX3, which together with four of its putative targets showed a robust response to a differentiation stimulus in healthy cells, whereas this regulatory mechanism was absent in PAC cells, emphasizing RUNX3 as a promising target for further studies. |
format | Text |
id | pubmed-3008686 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-30086862011-01-03 A Novel HMM-Based Method for Detecting Enriched Transcription Factor Binding Sites Reveals RUNX3 as a Potential Target in Pancreatic Cancer Biology Levkovitz, Liron Yosef, Nir Gershengorn, Marvin C. Ruppin, Eytan Sharan, Roded Oron, Yoram PLoS One Research Article BACKGROUND: Pancreatic adenocarcinoma (PAC) is one of the most intractable malignancies. In order to search for potential new therapeutic targets, we relied on computational methods aimed at identifying transcription factor binding sites (TFBSs) over-represented in the promoter regions of genes differentially expressed in PAC. Though many computational methods have been implemented to accomplish this, none has gained overall acceptance or produced proven novel targets in PAC. To this end we have developed DEMON, a novel method for motif detection. METHODOLOGY: DEMON relies on a hidden Markov model to score the appearance of sequence motifs, taking into account all potential sites in a promoter of potentially varying binding affinities. We demonstrate DEMON's accuracy on simulated and real data sets. Applying DEMON to PAC-related data sets identifies the RUNX family as highly enriched in PAC-related genes. Using a novel experimental paradigm to distinguish between normal and PAC cells, we find that RUNX3 mRNA (but not RUNX1 or RUNX2 mRNAs) exhibits time-dependent increases in normal but not in PAC cells. These increases are accompanied by changes in mRNA levels of putative RUNX gene targets. CONCLUSIONS: The integrated application of DEMON and a novel differentiation system led to the identification of a single family member, RUNX3, which together with four of its putative targets showed a robust response to a differentiation stimulus in healthy cells, whereas this regulatory mechanism was absent in PAC cells, emphasizing RUNX3 as a promising target for further studies. Public Library of Science 2010-12-22 /pmc/articles/PMC3008686/ /pubmed/21203558 http://dx.doi.org/10.1371/journal.pone.0014423 Text en This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. https://creativecommons.org/publicdomain/zero/1.0/ This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration, which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. |
spellingShingle | Research Article Levkovitz, Liron Yosef, Nir Gershengorn, Marvin C. Ruppin, Eytan Sharan, Roded Oron, Yoram A Novel HMM-Based Method for Detecting Enriched Transcription Factor Binding Sites Reveals RUNX3 as a Potential Target in Pancreatic Cancer Biology |
title | A Novel HMM-Based Method for Detecting Enriched Transcription Factor Binding Sites Reveals RUNX3 as a Potential Target in Pancreatic Cancer Biology |
title_full | A Novel HMM-Based Method for Detecting Enriched Transcription Factor Binding Sites Reveals RUNX3 as a Potential Target in Pancreatic Cancer Biology |
title_fullStr | A Novel HMM-Based Method for Detecting Enriched Transcription Factor Binding Sites Reveals RUNX3 as a Potential Target in Pancreatic Cancer Biology |
title_full_unstemmed | A Novel HMM-Based Method for Detecting Enriched Transcription Factor Binding Sites Reveals RUNX3 as a Potential Target in Pancreatic Cancer Biology |
title_short | A Novel HMM-Based Method for Detecting Enriched Transcription Factor Binding Sites Reveals RUNX3 as a Potential Target in Pancreatic Cancer Biology |
title_sort | novel hmm-based method for detecting enriched transcription factor binding sites reveals runx3 as a potential target in pancreatic cancer biology |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3008686/ https://www.ncbi.nlm.nih.gov/pubmed/21203558 http://dx.doi.org/10.1371/journal.pone.0014423 |
work_keys_str_mv | AT levkovitzliron anovelhmmbasedmethodfordetectingenrichedtranscriptionfactorbindingsitesrevealsrunx3asapotentialtargetinpancreaticcancerbiology AT yosefnir anovelhmmbasedmethodfordetectingenrichedtranscriptionfactorbindingsitesrevealsrunx3asapotentialtargetinpancreaticcancerbiology AT gershengornmarvinc anovelhmmbasedmethodfordetectingenrichedtranscriptionfactorbindingsitesrevealsrunx3asapotentialtargetinpancreaticcancerbiology AT ruppineytan anovelhmmbasedmethodfordetectingenrichedtranscriptionfactorbindingsitesrevealsrunx3asapotentialtargetinpancreaticcancerbiology AT sharanroded anovelhmmbasedmethodfordetectingenrichedtranscriptionfactorbindingsitesrevealsrunx3asapotentialtargetinpancreaticcancerbiology AT oronyoram anovelhmmbasedmethodfordetectingenrichedtranscriptionfactorbindingsitesrevealsrunx3asapotentialtargetinpancreaticcancerbiology AT levkovitzliron novelhmmbasedmethodfordetectingenrichedtranscriptionfactorbindingsitesrevealsrunx3asapotentialtargetinpancreaticcancerbiology AT yosefnir novelhmmbasedmethodfordetectingenrichedtranscriptionfactorbindingsitesrevealsrunx3asapotentialtargetinpancreaticcancerbiology AT gershengornmarvinc novelhmmbasedmethodfordetectingenrichedtranscriptionfactorbindingsitesrevealsrunx3asapotentialtargetinpancreaticcancerbiology AT ruppineytan novelhmmbasedmethodfordetectingenrichedtranscriptionfactorbindingsitesrevealsrunx3asapotentialtargetinpancreaticcancerbiology AT sharanroded novelhmmbasedmethodfordetectingenrichedtranscriptionfactorbindingsitesrevealsrunx3asapotentialtargetinpancreaticcancerbiology AT oronyoram novelhmmbasedmethodfordetectingenrichedtranscriptionfactorbindingsitesrevealsrunx3asapotentialtargetinpancreaticcancerbiology |